Corteva (NYSE:CTVA) Price Target Raised to $86.00

Corteva (NYSE:CTVA) had its price objective boosted by Wolfe Research from $81.00 to $86.00 in a research note issued to investors on Thursday morning,MarketScreener reports. They currently have an outperform rating on the stock.

A number of other brokerages have also recently commented on CTVA. Argus raised shares of Corteva to a “strong-buy” rating in a report on Friday, January 16th. Bank of America lifted their price objective on shares of Corteva from $80.00 to $82.00 and gave the company a “buy” rating in a research note on Thursday, January 8th. Deutsche Bank Aktiengesellschaft upped their target price on shares of Corteva from $85.00 to $90.00 and gave the company a “buy” rating in a report on Thursday. The Goldman Sachs Group reissued a “buy” rating and set a $88.00 price target on shares of Corteva in a report on Thursday. Finally, Rothschild & Co Redburn reduced their price objective on Corteva from $71.00 to $65.00 and set a “neutral” rating for the company in a research note on Tuesday, November 11th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $82.37.

Corteva Stock Up 0.2%

Shares of NYSE CTVA opened at $72.63 on Thursday. The stock has a market cap of $49.08 billion, a PE ratio of 45.97, a price-to-earnings-growth ratio of 1.84 and a beta of 0.75. The company has a quick ratio of 1.07, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. Corteva has a 52-week low of $53.40 and a 52-week high of $77.41. The business has a 50-day moving average price of $68.82 and a 200 day moving average price of $68.39.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting the consensus estimate of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. During the same quarter in the previous year, the company posted $0.32 earnings per share. The firm’s revenue was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts forecast that Corteva will post 2.96 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s dividend payout ratio is 45.57%.

Institutional Trading of Corteva

Institutional investors have recently modified their holdings of the business. Brighton Jones LLC raised its position in Corteva by 307.2% in the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after acquiring an additional 11,760 shares in the last quarter. Woodline Partners LP grew its stake in shares of Corteva by 40.3% during the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock worth $3,645,000 after purchasing an additional 16,644 shares during the period. Wealthcare Advisory Partners LLC purchased a new position in shares of Corteva in the 2nd quarter valued at about $213,000. Maryland State Retirement & Pension System increased its holdings in shares of Corteva by 1.7% in the 2nd quarter. Maryland State Retirement & Pension System now owns 33,251 shares of the company’s stock valued at $2,478,000 after purchasing an additional 552 shares in the last quarter. Finally, US Bancorp DE lifted its stake in shares of Corteva by 2.9% in the second quarter. US Bancorp DE now owns 264,780 shares of the company’s stock valued at $19,735,000 after purchasing an additional 7,502 shares during the period. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Key Headlines Impacting Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Several sell‑side firms lifted targets and kept bullish ratings, signaling analyst confidence in longer‑term upside: Deutsche Bank to $90 (buy), Wolfe Research to $86 (outperform), and RBC to $89 (outperform). Deutsche Bank raise Wolfe Research raise RBC raise
• Positive Sentiment: Brokerage consensus remains constructive (consensus “Moderate Buy”), which supports demand for the shares despite near‑term noise. Consensus Moderate Buy
• Positive Sentiment: Strategic commentary highlights Corteva’s expanding role in global agriculture and technology leadership—positive for medium‑term growth expectations. Corteva expands role
• Neutral Sentiment: Analyst views are mixed across publications — some highlight long‑term upside tied to licensing and settlements, while others argue valuation limits near‑term gains. Investors should weigh catalyst timing. Bull case analysis Conflicting analyst views
• Neutral Sentiment: Technical analysis pieces warn of a key structural test — useful for traders but not definitive for fundamentals; could increase short‑term volatility. Technical caution
• Negative Sentiment: Q4 results missed revenue expectations (seasonal timing and weaker crop‑protection/seed demand); revenue miss and a wider loss drove an after‑hours selloff. Those operational misses are the main near‑term headwind. Q4 revenue miss After‑hours fall
• Negative Sentiment: JPMorgan downgraded Corteva from overweight to neutral (citing valuation/limited near‑term upside), which can cool momentum among institutional buyers. JPMorgan downgrade
• Negative Sentiment: Market reaction to the earnings miss (seasonal timing) and mixed guidance elements increases short‑term uncertainty even as analysts argue for longer‑term upside — expect higher intraday volatility. Seasonal timing impact

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.